Cargando…

COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality

Detalles Bibliográficos
Autores principales:	Muthu, Valliappan, Agarwal, Ritesh, Chakrabarti, Arunaloke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188728/ https://www.ncbi.nlm.nih.gov/pubmed/35690964 http://dx.doi.org/10.1007/s11046-022-00638-5

Ejemplares similares

COVID-19, mucormycosis, and the cow: Damned lies!
por: Muthu, Valliappan, et al.
Publicado: (2023)

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021)

Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
por: Pruthi, Himanshu, et al.
Publicado: (2021)

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
por: Garg, Deepak, et al.
Publicado: (2021)

CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review
por: Garg, Mandeep, et al.
Publicado: (2021)

Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
por: Muthu, Valliappan, et al.
Publicado: (2022)

Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2023)

Pulmonary embolism: an underdiagnosed and underreported entity in Brazil
por: Miranda, Carlos Henrique
Publicado: (2022)

The minimal important difference of six-minute walk test in subjects with chronic pulmonary aspergillosis treated with six-months of oral itraconazole
por: Sehgal, Inderpaul S., et al.
Publicado: (2023)

Omphalolith: An underdiagnosed entity
por: Jouini, Wafa, et al.
Publicado: (2022)

Umbilical cord ulceration: An underdiagnosed entity
por: Maheshwari, Barkha, et al.
Publicado: (2016)

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
por: Patel, Atul, et al.
Publicado: (2021)

P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples
por: Choudhary, Hansraj, et al.
Publicado: (2022)

Amiodarone toxicity: An underdiagnosed entity
por: Xavier, Joseph, et al.
Publicado: (2016)

Follicular psoriasis: an underdiagnosed entity?
por: Souza, Bruno de Castro e, et al.
Publicado: (2019)

Hepatic Glycogenosis: An Underdiagnosed Entity?
por: Garcês Soares, Sofia, et al.
Publicado: (2022)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Allergic bronchopulmonary aspergillosis
por: Agarwal, Ritesh, et al.
Publicado: (2020)

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
por: Muthu, Valliappan, et al.
Publicado: (2022)

Global Epidemiology of Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2019)

Epidemiology of Mucormycosis in India
por: Prakash, Hariprasath, et al.
Publicado: (2021)

The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
por: Gupta, Amod, et al.
Publicado: (2021)

Allergic bronchopulmonary aspergillosis or pulmonary tuberculosis: A case of mistaken identity?
por: Muthu, Valliappan, et al.
Publicado: (2015)

Prevalence of Vitamin D Deficiency in Treatment-Naïve Subjects with Chronic Pulmonary Aspergillosis
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity
por: Dieu, Xavier, et al.
Publicado: (2020)

Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment-naïve subjects with chronic pulmonary aspergillosis
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2023)

The recent mucormycosis storm over Indian sky
por: Chakrabarti, Arunaloke
Publicado: (2021)

Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma
por: Agarwal, Ritesh, et al.
Publicado: (2022)

Mucormycosis and COVID-19 an epidemic in a pandemic?
por: Banerjee, Indrajit, et al.
Publicado: (2021)

Estimation of the Burden of Chronic and Allergic Pulmonary Aspergillosis in India
por: Agarwal, Ritesh, et al.
Publicado: (2014)

Poorly differentiated thyroid carcinoma: An underdiagnosed entity
por: Dettmer, M. S., et al.
Publicado: (2019)

Clindamycin-Induced Esophageal Injury: Is It an Underdiagnosed Entity?
por: Bestari, Muhammad Begawan, et al.
Publicado: (2019)

Alopecic and aseptic nodules of the scalp: an underdiagnosed entity
por: Sung, Kun-Yong, et al.
Publicado: (2022)

Eruptive Vellus Hair Cysts: An Underdiagnosed Entity
por: Patokar, Abhishek S., et al.
Publicado: (2022)

Mucormycosis in COVID-19 pandemic: Risk factors and linkages
por: Kumar, Manoj, et al.
Publicado: (2021)

COVID-19 and Mucormycosis: A Black Fungus Disaster?
por: Chillana, Suchira, et al.
Publicado: (2022)

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
por: Bhanuprasad, Kundakarla, et al.
Publicado: (2021)

Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?
por: Agarwal, Ritesh, et al.
Publicado: (2021)

Tuberculosis or not tuberculosis: Attente cogitanti
por: Muthu, Valliappan, et al.
Publicado: (2020)

Is bronchial thermoplasty safe in allergic bronchopulmonary aspergillosis or severe asthma with fungal sensitization?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ftt6kufdrr3mqkp10m80ncm9f